# Does Clinical Treatment of Mitochondrial Dysfunction Impact Autism Spectrum Disorder (ASD)?

> **NCT02348125** · PHASE1 · UNKNOWN · sponsor: **Drexel University** · enrollment: 50 (estimated)

## Conditions studied

- Autism Spectrum Disorders
- Mitochondrial Diseases

## Interventions

- **DRUG:** Mitochondrial Cocktail

## Key facts

- **NCT ID:** NCT02348125
- **Lead sponsor:** Drexel University
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2016-03
- **Primary completion:** 2017-06
- **Final completion:** 2017-06
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2017-04-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02348125

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02348125, "Does Clinical Treatment of Mitochondrial Dysfunction Impact Autism Spectrum Disorder (ASD)?". Retrieved via AI Analytics 2026-07-06 from https://api.ai-analytics.org/clinical/NCT02348125. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*